PI-RADS v2.1移行区「结节中结节」与「结节间均匀轻度低信号区」的前列腺癌检出率:MRI-根治性前列腺切除病理对照
回顾性纳入53例根治性前列腺切除证实的移行区肿瘤患者,3名盲法放射科医师按PI-RADS v2.1评估T2WI和DWI。结果「结节中结节」中前列腺癌比例低(约5-8%),「结节间均匀轻度低信号区」中未检出前列腺癌(95%CI上限24.7-52.2%)。仅当「结节中结节」内结节包膜缺失/不完整且DWI明显受限时检出临床显著癌。
要点
- 「结节中结节」中临床显著前列腺癌比例低,约5-8%。
- 「结节间均匀轻度低信号区」中未检出前列腺癌,可能为良性。
- 「结节中结节」内结节包膜缺失/不完整且DWI明显受限时需考虑前列腺癌。
关键影像表现/征象
- 「结节中结节」的「囊性变」在R1/R2/R3中分别为80.8%(21/26)、94.4%(17/18)、59.1%(13/22)。
- 「结节中结节」内结节包膜缺失/不完整在R1/R2/R3中分别为46.2%(12/26)、33.3%(6/18)、63.6%(14/22)。
- 「结节中结节」DWI评分≥4在R1/R2/R3中分别为7.7%(2/26)、5.6%(1/18)、9.1%(2/22)。
- 检出的前列腺癌均表现为内结节包膜缺失/不完整且DWI评分≥4。
- 其他移行区肿瘤均未显示「结节中结节」、结节「囊性变」或「结节间均匀轻度低信号区」。
诊断标准与关键数值
- 「结节中结节」中前列腺癌比例:R1为7.7%(2/26;95%CI 0.1-17.9%),R2为5.6%(1/18;95%CI 0.01-16.1%),R3为4.5%(1/22;95%CI 0.01-13.3%)。
- 「结节间均匀轻度低信号区」中前列腺癌:R1/R2/R3分别为5/6/13例中0例检出,95%CI上限分别为24.7-52.2%。
临床应用与阅片要点
- 阅片时「结节中结节」内结节包膜缺失/不完整且DWI明显受限时需考虑前列腺癌。
- 「结节间均匀轻度低信号区」在当前研究中未检出前列腺癌,可能为良性。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the prevalence of prostate cancer (PCa) of two PI-RADS version (v) 2.1 transition zone (TZ) features (PI-RADS 1 ['nodule in nodule'] and 2 ['homogeneous mildly hypointense area between nodules']).
METHODS: With an institutional review board approval, from a 5-year cohort between 2012 and 2017, we retrospectively identified 53 consecutive men with radical prostatectomy (RP) confirmed TZ tumors and MRI. Three blinded radiologists (R1/2/3) independently evaluated T2-weighted and diffusion-weighted imaging (DWI) using PI-RADS v2.1 for the presence of (1) 'nodule in nodule' (recording 'cystic change', inner nodule encapsulation, size, and DWI score) and (2) 'homogeneous mildly hypointense area between nodules' (also recording size and DWI score). MRI-RP maps established ground truth. Primary tumor was evaluated assessing PI-RADS v2.1 category, size, and presence of imaging variants.
RESULTS: R1/2/3 identified 26/18/22 'nodule in nodule' respectively with 7.7% (2/26; 95% confidence interval [95% CI]: 0.1-17.9%), 5.6% (1/18; 95% CI: 0.01-16.1%), and 4.5% (1/22; 95% CI: 0.01-13.3%) PCa (both Gleason score 3 + 4 = 7). Agreement was fair-to-substantial, kappa = 0.222-0.696. 'Cystic change', inner nodule absent/incomplete encapsulation and DWI score ≥ 4 for R1/R2/R2 were present in 80.8% (21/26), 46.2% (12/26), 7.7% (2/26); 94.4% (17/18), 33.3% (6/18), 5.6% (1/18); and 59.1% (13/22), 63.6% (14/22), 9.1% (2/22). Both PCa had inner nodule absent/incomplete encapsulation and DWI score ≥ 4. No other TZ tumors demonstrated 'nodule in nodule', nodule 'cystic change', or 'homogeneous mildly hypointense area between nodules'. R1/2/3 identified 5/6/13 'homogeneous mildly hypointense area between nodules' with zero PCa for any reader (upper bound 95% CI: 24.7-52.2%). Interobserver agreement was fair-to-substantial, kappa = 0.104-0.779.
CONCLUSION: The proportion of cancers in PI-RADS v2.1 'nodule in nodule' was low (~5-8%) with zero cancers detected in 'homogeneous mildly hypointense area between nodules'. When 'nodule in nodule' inner nodule shows absent or incomplete encapsulation with marked restricted diffusion, PCa may be considered; however, this warrants further studies.
KEY POINTS: • The prevalence of clinically significant prostate cancers in PI-RADS v2.1 'nodule in nodule' was low (5-8%, 95% CI: 0.1-17.9%). • Clinically significant prostate cancer was only detected in the 'nodule in nodule' variant when the inner nodule showed absent or incomplete encapsulation ('atypical nodule') with marked restricted diffusion. • 'Homogeneous mildly hypointense area between nodules' is likely benign with no cancers identified in the current study, however, with a wide 95% CI due to low prevalence.
引用
- Lim CS, Abreu-Gomez J, Flood TA, et al. Prevalence of prostate cancer in PI-RADS version 2.1 T2-weighted transition zone 'nodule in nodule' and 'homogeneous mildly hypointense area between nodules' criteria: MRI-radical prostatectomy histopathological evaluation. Eur Radiol. 2021. PMID: 33782767. doi:10.1007/s00330-021-07855-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。